Target intelligence / Profile preview

COX20 pseudogene 1 (COX20P1)

Target: COX20P1
Molecular classification: Other (pseudogene)

Overview

COX20 pseudogene 1 (COX20P1) is a noncoding genomic locus classified as a pseudogene derived from the COX20 gene, which encodes a mitochondrial chaperone involved in ataxia and mitochondrial complex IV assembly[2][4]. Pseudogenes, including COX20P1, do not encode functional proteins and are generally considered evolutionary relics, although a minority may play regulatory roles in rare cases[1][3]. There are currently no reports of COX20P1 being involved in any physiological or pathogenic process, nor is it recognized as a drug or disease target in clinical or biomedical literature.

Other names: bA119F7.2COX20P1

Beyond the preview

Go deeper on COX20 pseudogene 1 (COX20P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on COX20 pseudogene 1 (COX20P1).

Explore the full profile